seed
Stage
1
Investors
About
Phenomic uses machine learning to analyze single-cell and spatial transcriptomics data from human solid tumors to identify novel drug targets and develop immuno-oncology therapies.
Explore Phenomic's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.